2025
|
|
|
- CAS号:
- 879487-87-3
- 英文名:
- R-268712
- 英文别名:
- 2025;R-268712;R 268712;R268712;4-[2-Fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-1H-pyrazole-1-ethanol;1H-Pyrazole-1-ethanol, 4-[2-fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-;2-(4-(2-fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethanol;2-(4-(2-Fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-ol;renal fibrosis,Thy1 nephritis,Transforming growth factor beta receptors,glomerulonephritis,Transforming growth factor beta,ALK tyrosine kinase receptor,HFL-1,R 268712,glomerulosclerosis,CD246,Inhibitor,Cluster of differentiation 246,UUO,Anaplastic lymphoma kinase (ALK),R268712,inhibit,TGF-β,TGF-beta/Smad,CKD,R-268712,TGF-β Receptor,Anaplastic lymphoma kinase
- 中文名:
- 2025
- 中文别名:
- 化合物R-268712;ALK5抑制剂(R-268712);4-[2-氟-5-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]苯基]-1H-吡唑-1-乙醇;2-(4-(2-氟-5-(3-(6-甲基吡啶-2-基)-1H-吡唑-4-基)苯基)-1H-吡唑-1-基)乙醇
- CBNumber:
- CB53126704
- 分子式:
- C20H18FN5O
- 分子量:
- 363.39
- MOL File:
- 879487-87-3.mol
|
|
|
2025化学性质
-
沸点:
-
576.8±50.0 °C(Predicted)
-
|
-
密度:
-
1.34±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Sealed in dry,Store in freezer, under -20°C
-
|
-
溶解度:
-
DMSO : 125 mg/mL (343.98 mM)
-
|
-
酸度系数(pKa):
-
10.96±0.50(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to light yellow
-
|
2025性质、用途与生产工艺
R-268712是一种有效的选择性ALK5抑制剂, IC50为2.5 nM。
2025
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-12953 | 2025
R-268712 | 879487-87-3 | 5mg | 1100元 |
| 2024/04/30 | HY-12953 | 2025
R-268712 | 879487-87-3 | 10mM * 1mLin DMSO | 1210元 |
879487-87-3, 2025 相关搜索:
- 对照品
- 细胞生物学试剂
- 4-[2-氟-5-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]苯基]-1H-吡唑-1-乙醇
- 2-(4-(2-氟-5-(3-(6-甲基吡啶-2-基)-1H-吡唑-4-基)苯基)-1H-吡唑-1-基)乙醇
- 化合物R-268712
- ALK5抑制剂(R-268712)
- 879487-87-3
- 2-(4-(2-fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethanol
- renal fibrosis,Thy1 nephritis,Transforming growth factor beta receptors,glomerulonephritis,Transforming growth factor beta,ALK tyrosine kinase receptor,HFL-1,R 268712,glomerulosclerosis,CD246,Inhibitor,Cluster of differentiation 246,UUO,Anaplastic lymphoma kinase (ALK),R268712,inhibit,TGF-β,TGF-beta/Smad,CKD,R-268712,TGF-β Receptor,Anaplastic lymphoma kinase
- 2-(4-(2-Fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-ol
- 2025
- R 268712;R268712
- 4-[2-Fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-1H-pyrazole-1-ethanol
- 1H-Pyrazole-1-ethanol, 4-[2-fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-
- R-268712